Concepedia

Publication | Open Access

Final Analysis of a Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis

DOIFull Paper Access

561

Citations

8

References

2019

Year

Dereck Tait, Mark Hatherill, Olivier Van Der Meeren, Ann M. Ginsberg, Elana van Brakel, Bruno Salaun, Thomas J. Scriba, Elaine Jacqueline Akité, Helen Ayles, Anne Bollaerts,
New England Journal of Medicine

Abstract

Among adults infected with <i>M. tuberculosis</i>, vaccination with M72/AS01<sub>E</sub> elicited an immune response and provided protection against progression to pulmonary tuberculosis disease for at least 3 years. (Funded by GlaxoSmithKline Biologicals and Aeras; ClinicalTrials.gov number, NCT01755598.).

References

YearCitations

Page 1